Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, May 7, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/tk888p/specialty) has announced the addition of the "Specialty Injectables: Ten Key Markets to 2020" report to their offering.
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.
Key Topics Covered:
1. Executive Summary
4. Autoimmune Diseases
5. Multiple Sclerosis
8. Hormone Replacement
11. Reproductive Health
For more information visit http://www.researchandmarkets.com/research/tk888p/specialty
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.